D-Thiazolidine-4-carboxylic acid

D-Thiazolidine-4-carboxylic acid is a chiral, cyclic amino acid derivative featuring a thiazolidine ring that incorporates a stereogenic center at the 4-position and a carboxylic acid functionality suitable for salt formation and peptide-coupling chemistry. The ring contains both sulfur and nitrogen heteroatoms, enabling distinct coordination behavior and nucleophilic/reactive sites relative to standard aliphatic amino acids. The constrained heterocycle can participate in stereoselective transformations and can serve as a stable, conformationally defined scaffold in synthetic sequences. As a chiral amino acid intermediate, it can be converted into protected derivatives for controlled N- and C-terminal handling during downstream synthesis and derivatization.

1. Chiral Building Block

D-Thiazolidine-4-carboxylic acid serves as a chiral amino acid intermediate for stereoselective synthesis where a thiazolidine-containing stereocenter is preserved. The cyclic thiazolidine framework provides a rigid, conformationally constrained backbone that can be carried through protection, activation, and coupling steps while maintaining defined stereochemistry. Carboxylic acid activation enables conversion into amide-forming intermediates, while the ring heteroatoms can be used as handles for selective functional transformations. Downstream, the compound can be employed to generate enantiopure heterocycle-bearing analogs used in method development and chiral library construction.

2. Peptide Coupling Chemistry

D-Thiazolidine-4-carboxylic acid is suitable for peptide building block preparation when converted to the appropriate protected amino acid derivative. The free carboxyl group supports standard coupling strategies to form amide bonds, and the ring nitrogen can be protected to control chemoselectivity during sequential peptide assembly. The sulfur-containing heterocycle can influence coupling efficiency and subsequent deprotection logic, making protecting-group planning relevant for stepwise synthesis. Incorporation into short peptides or peptide-like scaffolds can enable exploration of thiazolidine-containing residues in peptide chemistry, including analog construction for backbone and side-chain property tuning.

3. Side-Chain Functionalization

D-Thiazolidine-4-carboxylic acid supports amino acid derivatization workflows that exploit the thiazolidine ring heteroatoms for functional group transformation. The sulfur and nitrogen within the ring can participate in nucleophilic substitution, oxidation/reduction adjustments, and coordination-driven steps that are less accessible with purely carbon-based side chains. Carboxylate chemistry enables esterification or conversion to activated intermediates, allowing controlled downstream attachment to polymers, linkers, or scaffold fragments. Functionalized derivatives derived from this chiral scaffold can be applied to generate targeted intermediates for fine chemical synthesis and chemical manufacturing routes requiring heterocycle-bearing stereochemical control.

4. Chemical Biology Probes

D-Thiazolidine-4-carboxylic acid can be applied in chemical biology research as a heterocycle-containing amino acid analog for studying molecular recognition and biomolecule interactions. The carboxylic acid enables conjugation-ready chemistry, while the thiazolidine ring provides a distinct electronic and steric environment that can modulate binding to protein sites or enzyme pockets. Protecting-group strategies can be used to manage N-/C-terminal reactivity during probe construction, including controlled installation of linkers for labeling or immobilization. Resulting conjugates and labeled derivatives can serve as research intermediates for biochemical assays, target engagement studies, and mechanistic investigations in applied peptide science.

5. Pharmaceutical Intermediate Preparation

D-Thiazolidine-4-carboxylic acid is relevant to pharmaceutical intermediate preparation where heterocyclic chiral building blocks are required for medicinal chemistry and process chemistry. The stereogenic thiazolidine ring and the carboxylic acid group enable conversion into activated forms for amide formation, ester intermediates, or protected derivatives aligned with downstream synthesis of drug-like scaffolds. Ring heteroatoms can be leveraged to tune physicochemical properties and provide reactive sites for late-stage modification, supporting manufacturing route design that maintains stereochemical integrity. Industrially, the compound can be used as a controlled chiral precursor in specialty chemical production for heterocycle-containing intermediates used across fine chemical synthesis programs.

6. Industrial Biocatalysis Feedstock

D-Thiazolidine-4-carboxylic acid can function as a defined chiral substrate or feedstock in industrial biocatalysis workflows aimed at heterocycle-containing compound generation. The carboxylic acid and cyclic N/S functionality provide functional groups that can be recognized in enzyme-mediated transformations, while the constrained stereocenter supports stereochemical outcomes in downstream products. Protecting-group selection can be used to align substrate reactivity with biocatalyst compatibility, enabling controlled formation of amide or ester derivatives after enzymatic steps. Resulting products derived from this amino acid-based intermediate can support specialty chemical production and applied process development where chiral heterocycle incorporation is required.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

3. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction